Showing 13 to 24 of 32 results
Blood Test Predicts Premature Birth Risk Four Months Early
A new Chinese study reveals a blood test predicting premature birth over four months prior, using circulating RNA biomarkers; while promising, its 16-21% false positive and 26-40% false negative rates necessitate further refinement before widespread implementation.
Blood Test Predicts Premature Birth Risk Four Months Early
A new Chinese study reveals a blood test predicting premature birth over four months prior, using circulating RNA biomarkers; while promising, its 16-21% false positive and 26-40% false negative rates necessitate further refinement before widespread implementation.
Progress
16% Bias Score
FDA Clears Lumipulse Blood Test for Early Alzheimer's Detection
The FDA cleared Lumipulse, a blood test detecting Alzheimer's amyloid plaques in symptomatic adults over 55, improving early diagnosis and access to new treatments, potentially reducing reliance on expensive and invasive procedures.
FDA Clears Lumipulse Blood Test for Early Alzheimer's Detection
The FDA cleared Lumipulse, a blood test detecting Alzheimer's amyloid plaques in symptomatic adults over 55, improving early diagnosis and access to new treatments, potentially reducing reliance on expensive and invasive procedures.
Progress
44% Bias Score
FDA-Approved Blood Test Revolutionizes Alzheimer's Diagnosis in Greece
The FDA-approved Lumipulse blood test, now available at the Ionian University's laboratory in Greece, offers a highly accurate, non-invasive method for diagnosing Alzheimer's disease, impacting 35 million individuals globally and potentially accelerating treatment.
FDA-Approved Blood Test Revolutionizes Alzheimer's Diagnosis in Greece
The FDA-approved Lumipulse blood test, now available at the Ionian University's laboratory in Greece, offers a highly accurate, non-invasive method for diagnosing Alzheimer's disease, impacting 35 million individuals globally and potentially accelerating treatment.
Progress
16% Bias Score
FDA Clears First Blood Test for Alzheimer's Diagnosis
The FDA approved Fujirebio Diagnostics' blood test for Alzheimer's diagnosis in those over 55 with symptoms; the test measures plasma proteins pTau217 and β-amyloid 1-42, showing 91% accuracy for positive and 97% for negative results in a study of almost 500 patients, offering a less invasive diagno...
FDA Clears First Blood Test for Alzheimer's Diagnosis
The FDA approved Fujirebio Diagnostics' blood test for Alzheimer's diagnosis in those over 55 with symptoms; the test measures plasma proteins pTau217 and β-amyloid 1-42, showing 91% accuracy for positive and 97% for negative results in a study of almost 500 patients, offering a less invasive diagno...
Progress
36% Bias Score
GP Warns of Vitamin D Overdose Risks: High Doses Linked to Heart, Kidney Damage
A UK general practitioner warns against high doses of vitamin D supplements due to the risk of heart and kidney damage from hypercalcemia, recommending blood tests before supplementation, noting that many exceed recommended daily limits of 4000 IU, and highlighting the fat-soluble nature of vitamin ...
GP Warns of Vitamin D Overdose Risks: High Doses Linked to Heart, Kidney Damage
A UK general practitioner warns against high doses of vitamin D supplements due to the risk of heart and kidney damage from hypercalcemia, recommending blood tests before supplementation, noting that many exceed recommended daily limits of 4000 IU, and highlighting the fat-soluble nature of vitamin ...
Progress
52% Bias Score
Blood Tests to Improve Alzheimer's Detection and Treatment
New blood tests for Alzheimer's disease, showing up to 91% improved diagnostic accuracy in research, could significantly improve detection and treatment, allowing earlier intervention with new FDA-approved drugs like Leqembi and Kisunla, while the ALZ-NET system will track long-term effects.
Blood Tests to Improve Alzheimer's Detection and Treatment
New blood tests for Alzheimer's disease, showing up to 91% improved diagnostic accuracy in research, could significantly improve detection and treatment, allowing earlier intervention with new FDA-approved drugs like Leqembi and Kisunla, while the ALZ-NET system will track long-term effects.
Progress
32% Bias Score
Proteomics to Launch Highly Accurate Endometriosis Blood Test
Proteomics International Laboratories will commercially launch PromarkerEndo, a highly accurate blood test for endometriosis, in Australia during the third quarter of 2024, using a 'traffic light' risk assessment system to improve early diagnosis and reduce the current seven-year average delay.
Proteomics to Launch Highly Accurate Endometriosis Blood Test
Proteomics International Laboratories will commercially launch PromarkerEndo, a highly accurate blood test for endometriosis, in Australia during the third quarter of 2024, using a 'traffic light' risk assessment system to improve early diagnosis and reduce the current seven-year average delay.
Progress
64% Bias Score
FDA Approves First Blood Test for Alzheimer's
The FDA approved a new blood test for Alzheimer's disease, increasing diagnostic accuracy to over 90% and improving access to treatment, particularly for those in underserved areas.
FDA Approves First Blood Test for Alzheimer's
The FDA approved a new blood test for Alzheimer's disease, increasing diagnostic accuracy to over 90% and improving access to treatment, particularly for those in underserved areas.
Progress
44% Bias Score
FDA Clears First Blood Test for Early Alzheimer's Detection
The FDA approved the Lumipulse G blood test for early Alzheimer's detection in adults over 55 with symptoms; it measures blood plasma proteins, correlating with brain amyloid plaques, but requires combined clinical data for diagnosis; the test shows 91.7% accuracy in clinical trials.
FDA Clears First Blood Test for Early Alzheimer's Detection
The FDA approved the Lumipulse G blood test for early Alzheimer's detection in adults over 55 with symptoms; it measures blood plasma proteins, correlating with brain amyloid plaques, but requires combined clinical data for diagnosis; the test shows 91.7% accuracy in clinical trials.
Progress
24% Bias Score
Annual Blood Tests Show Promise in Early Cancer Detection
Annual multi-cancer blood tests could prevent up to 49% of late-stage diagnoses, reducing deaths by 21% within five years, according to a study using a new test trialed by the NHS involving 8,000 patients, detecting up to 12 common cancers, and using AI to pinpoint cancer location.
Annual Blood Tests Show Promise in Early Cancer Detection
Annual multi-cancer blood tests could prevent up to 49% of late-stage diagnoses, reducing deaths by 21% within five years, according to a study using a new test trialed by the NHS involving 8,000 patients, detecting up to 12 common cancers, and using AI to pinpoint cancer location.
Progress
40% Bias Score
Survey Reveals Growing Desire for Early Alzheimer's Detection
A national Alzheimer's Association survey of 1,700 Americans aged 45+ reveals 79% want early Alzheimer's detection via blood tests, reflecting a shift in attitudes towards proactive healthcare and informed decision-making due to new diagnostic and treatment options.
Survey Reveals Growing Desire for Early Alzheimer's Detection
A national Alzheimer's Association survey of 1,700 Americans aged 45+ reveals 79% want early Alzheimer's detection via blood tests, reflecting a shift in attitudes towards proactive healthcare and informed decision-making due to new diagnostic and treatment options.
Progress
32% Bias Score
Blood Test Predicts Age-Related Disease Risk Through Organ-Specific Aging
A new blood test can predict the risk of 45 age-related diseases by identifying organs aging faster than expected, analyzing plasma protein signatures to determine biological age and its links to multimorbidity, with implications for preventive medicine and personalized healthcare.
Blood Test Predicts Age-Related Disease Risk Through Organ-Specific Aging
A new blood test can predict the risk of 45 age-related diseases by identifying organs aging faster than expected, analyzing plasma protein signatures to determine biological age and its links to multimorbidity, with implications for preventive medicine and personalized healthcare.
Progress
16% Bias Score
Showing 13 to 24 of 32 results